Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02746458
Other study ID # W81XWH-15-2-0067
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 1, 2016
Est. completion date August 1, 2024

Study information

Verified date April 2024
Source Major Extremity Trauma Research Consortium
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Rehabilitation Enhanced by Partial Arterial Inflow Restriction (REPAIR) Study will be conducted in a patient population of individuals recovering from a traumatic diaphyseal fracture of the femur. Although the intervention can be used for any patient with muscle weakness following trauma, the persistent thigh weakness that follows a femur fracture provides a perfect model for evaluating the effectiveness of the REPAIR protocol.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 250
Est. completion date August 1, 2024
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: 1. Adults ages 18-55 inclusive 2. Admitted to one of the participating clinical centers for operative treatment of a closed diaphyseal femur fracture with one of the following OTA codes: 32A, 32B or 32C (treated with an IM Nail). Exclusion Criteria: 1. Open diaphyseal femur fracture (except low velocity gunshot wounds) or severe crushing injuries to study limb. 2. Additional fracture, dislocations or soft tissue injuries to the study limb that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation. 3. Any fractures, dislocations or soft tissue injuries to the contralateral limb or pelvis that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation. 4. Any treatment of the study injury in either group that would preclude application of the tourniquet cuff (e.g. vascular reconstruction, wound, flap, or skin graft). 5. Injuries to other body systems (or other medical conditions) that would preclude the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation (e.g. spinal cord deficit; severe traumatic brain injury). 6. Use of blood flow restriction (BFR) at any time between treatment and the start of physical therapy for the study. 7. Non-ambulatory pre-injury. 8. Morbidly obese (BMI > 40). 9. History of Peripheral Artery Disease and/or Peripheral Vascular Disease (PAD/PVD). 10. Current or history of venous thromboembolism. 11. Impaired circulation or peripheral vascular compromise. 12. Previous revascularization at the study injury site. 13. Extremities with dialysis access. 14. Current diagnosis of acidosis. 15. Diagnosis of sickle cell anemia. 16. Current infection of the study injury. 17. Current tumor (malignant or benign) distal to study injury and future tourniquet placement. 18. Current use of medications or supplements that are known to increase clotting risk. 19. Diagnosis of severe hypertension (blood pressure of 180/110). 20. Skin grafts in which all bleeding points must be readily distinguished. 21. Secondary or delayed surgical procedures to study injury after immobilization. 22. Vascular grafting to the study injury. 23. History of lymphotomies. 24. Current diagnosis of cancer. 25. Unable to speak either English or Spanish. 26. Severe problems with maintaining follow-up (e.g. patients who are prisoners, homeless at the time of injury, who are intellectually challenged without adequate family support, or have document psychiatric disorders). 27. Unable to provide informed consent. 28. Patient has not been cleared to start physical therapy at the time of consent. 29. Patient is pregnant. 30. Patient received BFR between date of injury and start of Physical Therapy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Blood Flow Restriction
Brief and intermittent blood flow restriction via a Delfi PTSII Tourniquet System will be used during physical therapy.
Device:
Delfi PTSII Tourniquet System


Locations

Country Name City State
United States University of Maryland Medical Center Baltimore Maryland
United States Walter Reed National Military Medical Center Bethesda Maryland
United States Carolinas Medical Center Charlotte North Carolina
United States MetroHealth Cleveland Ohio
United States University of Texas Health Science Center at Houston Houston Texas
United States Methodist Hospital Indianapolis Indiana
United States Barnes Jewish Hospital Saint Louis Missouri
United States San Antonio Military Medical Center San Antonio Texas

Sponsors (1)

Lead Sponsor Collaborator
Major Extremity Trauma Research Consortium

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Knee Strength measured using a stabilized hand held dynamometer Knee strength will be measured using a stabilized hand held dynamometer in both the injured and uninjured legs. up to 6 months
Primary Muscle Volume assessed using mid-thigh girth circumference measurement Muscle volume will be assessed using mid-thigh girth circumference measurements. up to 6 months
Secondary Strength Strength will be measured using the sit to stand test. up to 6 months
Secondary Speed Speed will be evaluated using the self selected walking speed. up to 6 months
Secondary Speed Speed will be evaluated using the 40 yard shuttle run. up to 6 months
Secondary Posture Stability Postural stability will be evaluated using the single leg stance. Change in Functional Performance Measures at 3 months and 6 months
Secondary Agility Agility will be measured using the 4 step square test. up to 6 months
Secondary Agility Agility will be measured using the Illinois Agility Test. up to 6 months
Secondary Physical Function Physical Function will be evaluated by the Patient Reported Outcomes Measurement Information System physical function questionnaire. up to 1 year
Secondary Depression evaluated with a depression questionnaire Depression will be evaluated by the Patient Reported Outcomes Measurement Information System depression questionnaire. up to 1 year
Secondary Anxiety evaluated with an anxiety questionnaire Anxiety will be evaluated by the Patient Reported Outcomes Measurement Information System anxiety questionnaire. up to 1 year
Secondary Sleep Disturbance evaluated with a sleep disturbance questionnaire Sleep Disturbance will be evaluated by the Patient Reported Outcomes Measurement Information System sleep disturbance questionnaire. up to 1 year
Secondary Psychological outcome-Post Traumatic Stress (PTSD) measured using the standard PTSD Checklist (PCL) PTSD will be measured using the standard PTSD Checklist (PCL). up to 1 year
Secondary Return to Work and Work Productivity measured using the Work Productivity and Activity Impairment (WPAI) questionnaire Work productivity will be measured using the Work Productivity and Activity Impairment (WPAI) questionnaire. up to 1 year
Secondary Pain evaluated with a Pain Inference scale Pain will be evaluated by the Patient Reported Outcomes Measurement Information System Pain Inference scale. up to 1 year
Secondary Satisfaction with Care and Recovery assessed using the MedRisk Instrument for Measuring Patient Satisfaction with Physical Therapy Care (MRPS) This will be assessed using the MedRisk Instrument for Measuring Patient Satisfaction with Physical Therapy Care (MRPS). 3 months
Secondary Fracture Healing Fracture healing will be determined by clinical examinations. up to 1 year
Secondary Fracture Healing Fracture healing will be determined by radiographic examinations. up to 1 year
Secondary Complications The presence of all limb related complications will be recorded prospectively at each follow up visit, and categorized according to type, date diagnosed, severity, treatment and relation to the study injury. up to 1 year